Ironwood CFO Gregory Martini resigns, Ronald Silver named interim CFO

• Ironwood Pharmaceuticals CFO Gregory Martini resigned, effective May 15, 2026.
• Senior Vice President, Corporate Controller and Chief Accounting Officer Ronald Silver will serve as interim chief financial officer and principal financial officer from May 15, 2026.
• Silver joined Ironwood in 2018, became Senior Vice President, Corporate Controller and Chief Accounting Officer in January 2025, held prior accounting and financial reporting roles at Eze Software Group, previously worked at RSM.
• Martini’s departure was not tied to any dispute over financial reporting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-059814), on May 13, 2026, and is solely responsible for the information contained therein.